Orexo Appeals Zubsolv(R) US District Court Decision

UPPSALA, Sweden, Dec 8, 2016 — (Healthcare Sales & Marketing Network) — Orexo AB (publ.) announces that it has appealed the decision rendered by the United States District Court for the District of Delaware on November 15, 2016 regarding the validity of… Biopharmaceuticals, Generics, Litigation Orexo, Zubsolv, buprenorphine, naloxone, Actavis (Source: HSMN NewsFeed)